Marc Subirats
General Partner @ Nina Capital
Barcelona, Spain
Marc Subirats is a seed investor at Nina Capital in Barcelona focused on Health Care and Apps. Marc Subirats is the Partner at Nina Capital.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 86%
Last updated:
For AI agents: llms.txt
Industries Marc Subirats invests in
Stages Marc Subirats invests in
Countries Marc Subirats invests in
Investment Focus
Industry
- Health Care 3 (43%)
- Apps 1 (14%)
- Medical 1 (14%)
- Software 1 (14%)
- Life Science 1 (14%)
Stage
- Seed 4 (57%)
- Pre-Seed 1 (14%)
Country
- Germany 1 (14%)
- Bulgaria 1 (14%)
- United States 1 (14%)
- United Kingdom 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
io Health
|
Io Health Technologies LLC provides AI-driven tools for home health documentation and workflow automation in healthcare. | $2M / Seed / Oct 07, 2025 | |
Lillian Care
|
Lillian is building a nationwide network of health facilities in Germany. | $1.6M / Seed / Jun 18, 2024 | |
Zetta Genomics
|
Zetta Genomics manages large-scale genomic data for precision medicine. The company employs distributed database technology and best practice security techniques to leverage genomic data benefits while preserving data privacy. Zetta Genomics was founded in 2018 and is based in Cambridge, England. | $2.3M / Seed / Feb 08, 2024 | |
|
Lillian Care
|
Lillian is building a nationwide network of health facilities in Germany. | $2.6M / Pre-Seed / Aug 01, 2023 | |
|
Zetta Genomics
|
Zetta Genomics manages large-scale genomic data for precision medicine. The company employs distributed database technology and best practice security techniques to leverage genomic data benefits while preserving data privacy. Zetta Genomics was founded in 2018 and is based in Cambridge, England. | $2.4M / Seed / Apr 17, 2023 | |
Healee
|
Healee is a telehealth platform which benefits doctors and patients through convenient and accessible virtual contact. | $2M / Seed / Aug 30, 2022 | |
|
Zetta Genomics
|
Zetta Genomics manages large-scale genomic data for precision medicine. The company employs distributed database technology and best practice security techniques to leverage genomic data benefits while preserving data privacy. Zetta Genomics was founded in 2018 and is based in Cambridge, England. | $3.4M / Seed / Feb 01, 2022 |
Co-Investors
About Nina Capital
Investing in healthcare transformation powered by information technology led by need-driven founders.
Nina Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Giangiacomo Rocco
Venture Partner
|
|||
Jordi Pedrol
Head of Finance
|
|||
|
Marc Subirats
General Partner
|
|||
Marta G. Zanchi
Founder & Managing Partner
|
|||
Matthew Holt
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Marc Subirats invest in?
Marc Subirats invests primarily in Health Care, Apps and Medical startups, most often at Seed and Pre-Seed stage. Most of the 7 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Marc Subirats last invest?
The most recent investment recorded for Marc Subirats closed in Oct 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
